Skip to content
Tirzepatide Report
Provider review

ReadyRx Tirzepatide Review: Monthly, Quarterly & Refund Terms

Published by Tirzepatide ReportUpdated

On this page

Tirzepatide plans with $185 monthly or $145/month equivalent paid quarterly upfront.

Standout details

  • Selected monthly and quarterly cards distinguish payment terms
  • Consultation and physician messaging listed as included

Things to consider

  • Quarterly headline requires upfront payment
  • Early renewal processing can shorten cancellation window

ReadyRx’s selected Monthly tirzepatide card displayed $185 for the first month and $185 per month afterward on October 25, 2026. Its Quarterly card displayed $145 per month, expressly tied to a quarterly plan paid upfront. The hero also advertised “from $145” beside a crossed-out $315. Read the selected plan and upfront requirement together; the $145 figure is not a $145 monthly bill.3

A promotional banner also advertised an extra discount code, but this review does not assume that code stacks with either card or calculate an unobserved checkout charge. No enrollment or payment was completed.

Selected tirzepatide payment plans

ItemPublished terms
Monthly card$185 first month; $185/month after
Quarterly card$145/month equivalent; paid upfront
Hero headlineFrom $145; not a stand-alone monthly bill
Included careConsultation, messaging, coaching and shipping listed
Selected tirzepatide payment plans

What the public program includes

ReadyRx describes personalized, online cash-pay care. The treatment cards list meal plans and coaching, free shipping and unlimited physician messaging. The product FAQ says a medical consultation is included and a licensed provider decides whether treatment is appropriate. A card labeled “Every Dose” is a pricing claim, not permission to choose or change a dose without a clinician.3

The company markets third-party testing for potency, sterility, pH and endotoxins. These are meaningful types of testing to ask about, but a list of tests is not independent verification of a particular dispensed batch. Likewise, the site’s pharmacy-registration and clinician-certification language does not identify or independently validate the actual pharmacy or clinician assigned to you.3

ReadyRx’s Terms identify Ready Health Ventures Inc. as the platform operator, with independent medical groups and third-party pharmacies delivering clinical and dispensing services. They allow prescriptions to move between participating pharmacies. Ask for the actual dispenser and product information when treatment is prescribed; do not assume the storefront itself compounds medication.4

Compounded medication is a separate product

The page acknowledges that personalized compounded GLP-1 medications are not FDA-approved. References elsewhere to approved GLP-1 medicines or clinical weight-loss studies do not turn the advertised compounded preparation into an approved finished drug. Our guide to whether compounded tirzepatide is still legal in 2026 explains the separate regulatory context.

Product format, ingredients and pharmacy instructions matter independently of the advertised rate. The reviewed page shows a compounded tirzepatide vial, while its generic delivery wording also refers to tablets. That wording alone does not establish a separate named oral tirzepatide offer or clinical equivalence between routes. Confirm the actual prescription instead of selecting on a general catalog description.3

Renewal can happen before the expected date

The Terms, modified September 23, 2026, say subscriptions renew automatically. They require cancellation at least four business days before the applicable renewal processing date, say the first renewal may be charged early, and allow later charges and shipments up to three days early for operational reasons. Counting back from an assumed delivery date can therefore miss the relevant deadline.4

The subscription section permits an email cancellation request, while the refund section says cancellation must be initiated, documented and completed through the customer dashboard. Use the documented account route and obtain confirmation; do not assume sending an unanswered email necessarily completes cancellation. Paused subscriptions resume charging if not canceled before the pause ends.4

Renewal and refund boundaries

ItemPublished terms
Cancellation cutoffFour business days before renewal processing
Early processingFirst renewal early; later charge/ship up to three days early
Unused timeGenerally nonrefundable; discretionary exceptions
California overrideFuture pharmacy submission cancellation has separate terms
Renewal and refund boundaries

The general rule is no refund for partially used subscription periods, with discretionary exceptions. Processed, shipped or delivered orders are generally nonrefundable. A separate provision addresses prepaid drug unavailability: an alternative may be offered, with a prorated refund if no suitable alternative is available. That limited remedy is not a general right to recover unused prepaid medication costs whenever a patient cancels.4

Read the guarantee and California terms separately

The weight-loss guarantee is conditional, not an approval or satisfaction refund. The Terms require an initial 28-week program, progress documentation and other eligibility, treatment and verification conditions. Any approved refund is limited to Program Membership Fees for the first seven months, excluding incidental costs. These terms do not guarantee a full medication refund and are not medical dosing advice.4

A California-specific section expressly supersedes conflicting general provisions for California members. It permits cancellation of future prescription submissions through the dashboard; a timely request before pharmacy submission prevents further charge or shipment for that canceled product. It also requires charge and shipment notices. Do not apply that stated California override to every jurisdiction or assume it reverses an already submitted order.4

Clinical monitoring remains essential

Confirm how follow-up, adverse-effect questions and any treatment transition are handled. A long prepaid plan does not establish ongoing medical suitability. Discuss Zepbound side effects, the gallbladder risk, and the thyroid cancer warning with your clinician rather than relying on testimonials or a laboratory-testing claim.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

Compare the plan you would actually buy

ReadyRx publishes a lower monthly equivalent for quarterly prepayment, but its processing deadlines and refund limits belong alongside that figure. Premium Health and Ondra Health have their own current arrangements; their pharmacy disclosures or policies do not apply here. Use the provider comparison after confirming the selected payment term, renewal date and complete prescribed supply.

Frequently asked questions

Is tirzepatide $145 monthly?

The $145/month figure belongs to a quarterly plan paid upfront. The selected Monthly card displayed $185 initially and afterward.3

Is the medical consultation included?

The product FAQ says the consultation is included; prescribing remains a clinical decision.3

Can I cancel the day before renewal?

The general Terms require at least four business days before renewal processing and allow early charges. Dashboard and email instructions differ, so obtain documented confirmation.4

Does the guarantee mean a full refund?

No. It has extensive eligibility and verification conditions and limits approved refunds to Program Membership Fees, excluding incidental costs. California future-order cancellation has a separate override.4

References(4)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. Read source
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. Read source
  3. ReadyRx (2026). Tirzepatide product page, selected Monthly and Quarterly cards. ReadyRx.
  4. ReadyRx (2026). Terms of Use, modified September 23, 2026. ReadyRx.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.